ClinicalTrials.gg
RecruitingNCT05114876PROMoTEUpdated Sep 12, 2025

Redesigning the Surgical Pathway (PROMoTE)

An interventional study of Multicomponent delirium-risk prevention bundle in Delirium, Cognitive Impairment and Perioperative/Postoperative Complications, sponsored by Sunnybrook Health Sciences Centre. Recruiting at 1 site in Canada. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2025-09-12.

Sponsored by Sunnybrook Health Sciences Centre · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Dec 2021; still recruiting 4 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 80 studies in Delirium with a site in Canada — 16 open to participants now, 24 under way, 2 of them phase 3. Delirium · Canada.

Planned enrollment
13th of 53
260 · median 88
Started
2021
with 7 others
No phase
33 of 80
6 open now
Primary completion
2025-12
later than 8 of 23 live
Registered
64th of 80
by date
Lead sponsor
5 of 80
Sunnybrook Health Sciences Centre

Among the 80 studies in Delirium with a site in Canada, this one is the 13th largest by planned enrollment of the 53 interventional ones that give a count, is one of 8 that started in 2021, is one of 33 with no phase, reaches primary completion later than 8 of the 23 other live ones, and was the 64th registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

16 of the 80 studies in Delirium with a site in Canada are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 80 studies in Delirium with a site in Canada, or all of them as a file.
02

Study summary

Cognitive complications, that is problems with thinking and memory, are incredibly common after surgery, occurring in 10-50% of all older surgical patients. These complications can take different forms, but one of the most common is postoperative delirium (POD), a short-term state of confusion. In addition to being stressful for patients and their families, POD is linked to longer hospital stays, increased costs, higher mortality rates and other problems after surgery. Despite this, POD is often not recognized by doctors and there are currently no effective medications to treat POD. However, simple strategies such as helping patients to sleep properly and remain hydrated, have been shown to help.

This study is testing if a delirium-reduction program will reduce postoperative delirium (POD) in older surgical patients. The investigators will first test memory and thought processes before surgery to find people who are most likely to develop POD. Once these people have been identified, they will be enrolled in a program which includes recommendations for their care team (e.g. surgeon, anesthesiologist, nurses) as well as educational materials for them and their family related to things that can be done to prevent delirium. By identifying at-risk patients and making sure that their doctors and caregivers are aware of how to prevent delirium, the investigators expect that this study will make surgery safer for older surgical patients.

Read the detailed description

Postoperative delirium (POD), an acute, reversible disturbance in brain function characterized by fluctuating levels of consciousness, attention and cognition is a common postoperative complication in older surgical patients. POD is associated with increased morbidity, mortality, and risk of dementia; in addition to longer hospital stays and increased healthcare costs. Despite this, POD frequently goes unrecognized by healthcare providers and is often poorly proactively managed. There are currently no effective pharmacological treatments for POD, although non-pharmacological prevention strategies (e.g. promoting sleep hygiene, hydration, and early mobilization) have proven effective.

This will be a two-phase, prospective, observational comparative study in patients (age ≥60) presenting for major, elective surgical procedures with an expected postoperative stay ≥1 day(s). In both phases, baseline cognitive screening will be used to identify individuals with evidence of pre-existing cognitive impairment (pre-CI), a key risk factor for POD, and only individuals with pre-CI will be eligible to continue in the study.

Phase I will establish the prevalence of POD and pre-CI in our patient population at Sunnybrook Health Sciences Centre, a tertiary care academic health sciences centre, and act as a control group for Phase II. Phase II will evaluate the effects of a comprehensive delirium-risk prevention bundle, which includes direct-to-patient education and healthcare provider awareness strategies. Participants in both Phase I and Phase II will provide written/verbal informed consent.

In each phase the study team will complete delirium assessments for 130 patients at baseline and on postoperative days 1-3. Demographic and clinical data will be abstracted from participants medical records. PHQ-9 (depression) and AD-8 (dementia screening interview) questionnaires will be completed at baseline.

03

Conditions studied

  • Delirium
  • Cognitive Impairment
  • Perioperative/Postoperative Complications
  • Cognitive Dysfunction
  • Cognitive Decline

Keywords

  • perioperative neurocognitive disorders
  • postoperative delirium
  • delirium
  • pre-existing cognitive impairment
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 60 years old
  • Undergoing major elective surgery (e.g., intra-abdominal, retroperitoneal, major orthopedic) with an expected postoperative stay of at least 1 night
  • Evidence of cognitive impairment on baseline screening tests (i.e. any score \< 90 on CBB or >10 on S-OMCT)

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing cardiac surgery
  • Patients undergoing intracranial neurosurgery
  • Patients with known substance use disorder (verbally declared by patients)
  • Unlikely to comply with study assessment (e.g., no fixed address, without access to internet/computer/phone).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
260 participants (estimated)

Study arms

  • No intervention
    Standard of Care

    Standard of care

  • Active comparator
    Intervention

    Multicomponent delirium-risk prevention bundle

    Other: Multicomponent delirium-risk prevention bundle

Interventions

  • OtherMulticomponent delirium-risk prevention bundle

    This multidisciplinary intervention will introduce new practices including: 1. Direct-to-Patient Education Program 2. Directly informing anesthesia and surgery teams about high-risk patients by flagging their chart, and providing suggestions for POD mitigation 3. Flag charts as high risk for POD so that nursing staff in both the PACU and the wards are aware, facilitating implementation of CHASM interventions (i.e. evidence-based delirium prevention protocols). 4. Reinforce CHASM best practices with regular educational sessions for nurses.

06

What researchers measure

Primary outcomes

  1. Incidence of POD before and after implementation of an institutional prospective diagnostic program.

    POD evaluated by 3D-CAM and retrospectively using the CHART-DEL method

    Time frame: twice daily on postoperative days 1-3, morning/late afternoon

Secondary outcomes

  1. Delirium Severity

    Assessed using CAM-S

    Time frame: twice daily on postoperative days 1-3, morning/late afternoon

  2. Hospital length of stay

    Duration of hospital admission in days

    Time frame: Until discharge, average of 1 week

  3. Unit adherence rate to CHASM principles

    Unit adherence rate to CHASM principles

    Time frame: Until discharge, average of 1 week

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All de-identified participants data collected during this trial that underlie the results reported in the publication(s) will be available upon request after publication of the primary results.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Data will be available upon request immediately after publication of the primary results. No end date.

Access criteria: Direct request to PI. Anyone who wishes to access the data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2021 (actual). Primary completion is estimated for Dec 2025, 48 months after the start.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 48 months is above that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2021
First posted
Nov 10, 2021
StartActual
Dec 13, 2021
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Sep 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05114876
Responsible party
Sponsor
First posted
Nov 10, 2021
Start date
Dec 13, 2021
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Sep 12, 2025

Study contacts

Stephen Choi, MD, MSc
Contact
stephen.choi@sunnybrook.ca
416-480-4864
Lilia Kaustov, PhD
Contact
lilia.kaustov@sunnybrook.ca
416-480-6100 ext. 89607
Stephen Choi, MD, MSc
principal investigator · Sunnybrook Health Sciences Centre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion